Idea for MRNA:
- Contrarian bet
- Investors believing that Nu variant will be a boon for Moderna and vaccine stocks.
- I think the opposite. Exit for Vaccine pump and dumpers before the bear market.
- Either the Nu var is a ruse, and we dont need boosters (bearish MRNA)
- Or Nu var is resistant to all vaccines (bearish MRNA)
Either way, very cheap to fade it...
Pfizer's monopoly is very strong on the Covid-19 vaccines . They are spending millions hiding their side effects and creating hurdles for their competitors at the regulatory agencies SUCCESSFULLY . It maybe that Novavax has one the best products out there but that simply does not matter at this point , we know how powerful big pharma can be and Novavax's lateness...
anti-vaxing people are real people too...they deserve a life or whatever who caress covid resistent pill for those needle fears loud spoken walking diseases, pump this shit up to the triple digits and dont say a goddamn word
Stocks trend. A lot. Much more than Forex. Pfizer is going parabolic while breaking all time high and $50, this could be the start of a big trend, or it might not.
Let's look at a few examples starting with Pfizer.
Clearly we see how with stocks we can make big multiples of our risk.
Like 25R in stocks versus 10R in Forex...
After the IPCC's recent report showing that the North Atlantic Current may be on its last legs, I decided that I needed to diversify away from the US and Europe a bit. (If the North Atlantic Current fails, it would cause massive, disruptive climate change for Europe and North America.) So I committed to look for opportunities in some country ETFs.
The one I've...
MRNA seems to have entered another downward channel trend.
Using the previous resistance on the last downward channel trend we can see it can act as a sort of support, the trend also made two other downward resistances as you can see on the chart.
This makes me to believe that this could go back down to $120 where it can make a double bottom which can be a great...
· Current Price – $0.0419
· Best Case Scenario PT over 1$
· Market Cap – $11 million
· Debt – 0
Are a biomedical company with a clear aim to revolutionize the world of medicine. They are working towards a creation of variety of antibodies and treatments using extracorporeal techniques (outside of body). They believe they have the...
POSSIBLE PATTERN :
- BULLISH PENNANT
※ DON'T FORGET TO USE TRAILING STOP 5%
※ ENTRY BUY:
- BUY ON BREAK OUT: 1645
- ENTRY BUY AT RANGE PRICE OF 1615 - 1665 (OPTIONAL)
(CLOSEST RESISTANCE TO BE BREAK IS AT 1685)
※ TARGET PROFIT 1: 1875 (FIBONACCI...
I want to apologize for my lack of activity the past few months. A lot has changed in the markets and a lot has evolved in my approach to reading and navigating the markets. When it comes to my process, I have added the use of multiple lenses beginning first with a fundamental macro overlay called the GIP (Growth, Inflation, Policy) Quad Model, which give us 4...
MYX:HWGB-WD is poised to retest its .815 retracement level after successfully broken the downtrend resistance. It has also succesfully bounced from the RBS and now is ready to fly to the next roof.
Currently its mother trades just shy below RM1 while its peers like MYX:SOLUTN and MYX:BINTAI had already broken past RM1 and maintain above that level.
An interesting trend on BNTX, complete wave II with a clear end of correction on main channel. Wave III is currently underway. Hope you find the chart interesting.
Please leave a like or drop your comment below and follow me for more updates.
This MUST NOT be taken as a trading signal.
No one can predict the result of NVAX's phase 3 trial. However, I don't count out any potential winners in the vaccine race even though now it seems very likely that NVAX won't be the first one to distribute vaccines at massive scale.
That being said, as long as the result of phase 3 trial isn't a complete failure, I think the crowd frenzy will keep pushing...
S&P 500 Index (SPX) (October 26th through November 9th 2020)
Low: 3362.9 points
High: 3455 points
How E-mini futures market started off yesterday:
My previous SPX forecast:
My adjustments today are more to correct the...